Related Experiment Video
Updated: Mar 12, 2026

Colony Formation Assay Detecting the Proliferative Capacity of LncRNA-knockdown Osteosarcoma Cells
Published on: January 16, 2026
Knockdown of long non-coding RNA CCAT2 suppressed proliferation and migration of glioma cells
Hua Guo1, Guowen Hu1, Qing Yang2
1Department of Neurosurgery, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Abstract:
Long non-coding RNA colon cancer-associated transcript 2 (CCAT2) is commonly investigated in a number of cancers. However, little is known of its expression and biological function in glioma biology. In the current study, we used quantitative real-time PCR (qRT-PCR) to determine the expression of CCAT2 in glioma tissues. We found that expression of CCAT2 was up-regulated in glioma tissues and significantly correlated with the advanced tumor stage (III/IV). Functional assays in vitro and in vivo demonstrated that knockdown of CCAT2 could inhibit proliferation, cell cycle progression and migration of glioma cells. Further analysis indicated the effect of CCAT2 knockdown on glioma cell phenotype through inhibiting Wnt/β-catenin signal pathway activity. Thus, our study provides evidence that CCAT2 may function as a potential biomarker for glioma.
Insights
Long non-coding RNA colon cancer-associated transcript 2 (CCAT2) is upregulated in glioma and promotes tumor growth. Inhibiting CCAT2 may offer a new therapeutic strategy for glioma patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Long non-coding RNAs (lncRNAs) are increasingly recognized for their roles in cancer.
- Colon cancer-associated transcript 2 (CCAT2) is implicated in various cancers, but its function in glioma remains unclear.
Purpose of the Study:
- To investigate the expression and biological function of CCAT2 in glioma.
- To explore the potential of CCAT2 as a diagnostic or therapeutic target in glioma.
Main Methods:
- Quantitative real-time PCR (qRT-PCR) was used to measure CCAT2 expression in glioma tissues.
- In vitro and in vivo functional assays were performed to assess the effects of CCAT2 knockdown.
- Western blotting and other molecular techniques were employed to analyze signaling pathways.
Main Results:
- CCAT2 expression was significantly upregulated in glioma tissues, correlating with advanced tumor stages (III/IV).
- Knockdown of CCAT2 inhibited glioma cell proliferation, cell cycle progression, and migration.
- CCAT2 knockdown suppressed glioma cell phenotypes by inhibiting the Wnt/β-catenin signaling pathway.
Conclusions:
- CCAT2 plays a crucial role in glioma progression.
- CCAT2 may serve as a potential biomarker and therapeutic target for glioma.
Related Concept Videos
lncRNA - Long Non-coding RNAs
Experimental RNAi
